Monday December 01 2008 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
  • A-Z

Fujitsu appointed as InforSense's Distributor of New Kensington Discovery Station Software for Japan

London, UK, July 7th 2003 - InforSense Ltd., the leading provider of discovery informatics platforms today announced a distribution agreement with Fujitsu Limited, a leader in customer-focused IT and communications solutions for the global marketplace, headquartered in Tokyo, Japan.  Fujitsu will act as the distributor in Japan of the forthcoming Kensington Discovery Station, the desktop version of InforSense’s popular Kensington Discovery Edition.  Fujitsu will also provide direct technical support within Japan for Discovery Station customers. 

 

“We are delighted that Fujitsu has joined with InforSense to extend the promotion and support of our leading Kensington platform in Japan,” said Prof. Yike Guo, CEO of InforSense. “Fujitsu brings immense, successful experience marketing and supporting informatics solutions within the Japanese Life Science community."

 

“Fujitsu is pleased to partner with InforSense to provide world-class data-mining and knowledge management solutions to our customers,” added Shunji Matsumoto, Manager, BioIT Laboratory for Fujitsu. “By incorporating the Discovery Station software with our wide range of Fujitsu software, hardware and services, we can provide our life science customers with state-of-the-art discovery solutions.”

 

About InforSense

InforSense Ltd. is a leading provider of discovery informatics software and services for the life science industry.  Its expertise is in the development of high performance enterprise wide discovery planning systems, which combine flexible process and knowledge management with large-scale data mining, analysis and visualization.

 

InforSense customers include major pharmaceutical and biotechnology companies, as well as academic research institutions.  InforSense has distribution deals with companies in Japan and Europe, a co-selling agreement with IBM in Europe, and a joint venture with IBM China.  InforSense Ltd. is a private company based in London, UK, with a US office based in Cambridge, MA.  Major shareholders include Imperial Fleming Family & Partners Gordon House LLP and NPI Ventures (a subsidiary of Nikko Cordial Corporation).

 

About Kensington Discovery Edition

InforSense's flagship product Kensington Discovery Edition™ is an advanced informatics environment designed to support large-scale information-driven discovery in life sciences.  For life science organizations Kensington offers the following advantages:

·         Enterprise Data Integration - dynamic integration of multi-domain, multi-modal data enabling scientists to access and exploit the information they need.

·         Flexible Workflow Management - intuitive data-processing workflows using supplied, proprietary or third-party components as workflow nodes.

·         Powerful Integrative Mining, Analysis and Visualization - a comprehensive range of advanced software components for identifying trends and making discoveries.

·         Efficient Application Generation - fast in-silico process analysis, workflow building and deployment to users, saving time and resources.

 

Kensington and its life science components support the requirements of the entire discovery life cycle and effectively increase the productivity of life science research.  To learn more, please visit www.inforsense.com .

 

About Fujitsu

Fujitsu is a leading provider of customer-focused IT and communications solutions for the global marketplace. Pace-setting technologies, highly reliable computing and telecommunications platforms, and a worldwide corps of systems and services experts uniquely position Fujitsu to deliver comprehensive solutions that open up infinite possibilities for its customers' success. Headquartered in Tokyo, Fujitsu Limited (TSE:6702) reported consolidated revenues of 4.6 trillion yen (US$38 billion) for the fiscal year ended March 31, 2003. For more information, please see: www.fujitsu.com

 

For more information please contact:

At the company                                   Media Contact           

Dr. Judith Bandy                                    Dr Nicola Reed Jones
InforSense Ltd                                       Northbank Communications Ltd

+44 (20) 7594 7927                               +44 (0) 1260 296500

jbandy@inforsense.com                         n.reedjones@northbankcommunications.com

 

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright © 1997-2008 - BioPortfolio Limited.